SCHEMBL8970495

SCHEMBL8970495

O=C1N(c2ccccc2)c2ccccc2S(=O)(=O)N1CCCCBr

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 6/20 0.42
DRD2 P14416 5/20 0.42
DRD4 P21917 1/20 0.42
DRD5 P21918 1/20 0.42
DRD3 P35462 1/20 0.42
HTR1A P08908 4/20 0.41
HTR2A P28223 4/20 0.41
HTR6 P50406 4/20 0.41
CA9 Q16790 4/20 0.40
CA12 O43570 3/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.37
ACHE P22303 2/20 0.37
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA2 P00918 1/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9134837 0.79 CA12 (0.34) HTR7DRD2DRD4DRD5DRD3
Acrylonitrile SCHEMBL9777606 0.79 KDM4E (0.51) HTR7DRD2HTR1AHTR2AHTR6
SCHEMBL9481255 0.77 HTR1A (0.64) HTR7DRD2DRD4DRD5DRD3
SCHEMBL9400841 0.74 HTR1A (0.64) HTR7DRD2DRD4DRD5DRD3
SCHEMBL4056129 0.73 SLC6A2 (0.52)
SCHEMBL9130214 0.73 CA9 (0.51) HTR7DRD2DRD4DRD5DRD3
SCHEMBL6324557 0.72 CA9 (0.73) HTR7DRD2DRD4DRD5DRD3
SCHEMBL9133993 0.71 DRD2 (0.47) HTR7DRD2DRD4DRD5DRD3
SCHEMBL5354797 0.71 CA9 (0.71) HTR7DRD2DRD4DRD5DRD3
SCHEMBL4033933 0.71 CA9 (0.71) HTR7DRD2DRD4DRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
US-5453437-A 1,3-disubstituted pyrrolidines BAYER AKTIENGESELLSCHAFT (DE) 1995-09-26 US disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5274097-A A 1-N-heterocyclic alkylene-3-carbo or heterocyclic ring oxypyrrolidine derivative BAYER AKTIENGESELLSCHAFT (DE) 1993-12-28 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed